Shanghai Aohua Photoelectricity Endoscope Co., Ltd.

XSSC:688212 Stock Report

Market Cap: CN¥6.7b

Shanghai Aohua Photoelectricity Endoscope Valuation

Is 688212 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688212 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688212 (CN¥49.5) is trading below our estimate of fair value (CN¥88.89)

Significantly Below Fair Value: 688212 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688212?

Key metric: As 688212 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688212. This is calculated by dividing 688212's market cap by their current earnings.
What is 688212's PE Ratio?
PE Ratio133.3x
EarningsCN¥49.97m
Market CapCN¥6.66b

Price to Earnings Ratio vs Peers

How does 688212's PE Ratio compare to its peers?

The above table shows the PE ratio for 688212 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.6x
688389 Shenzhen Lifotronic Technology
17.5x20.5%CN¥6.7b
688581 HangzhouS MedTech
17.9x22.3%CN¥4.9b
688410 SWS Hemodialysis Care
54.8x42.4%CN¥4.1b
301087 Cofoe Medical TechnologyLtd
28.4xn/aCN¥7.5b
688212 Shanghai Aohua Photoelectricity Endoscope
133.3x59.8%CN¥6.7b

Price-To-Earnings vs Peers: 688212 is expensive based on its Price-To-Earnings Ratio (133.3x) compared to the peer average (29.6x).

Price to Earnings Ratio vs Industry

How does 688212's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688212 133.3xIndustry Avg. 36.6xNo. of Companies17PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688212 is expensive based on its Price-To-Earnings Ratio (133.3x) compared to the CN Medical Equipment industry average (36.6x).

Price to Earnings Ratio vs Fair Ratio

What is 688212's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688212 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio133.3x
Fair PE Ratio55.5x

Price-To-Earnings vs Fair Ratio: 688212 is expensive based on its Price-To-Earnings Ratio (133.3x) compared to the estimated Fair Price-To-Earnings Ratio (55.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688212 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥49.50
CN¥59.13
+19.5%
9.1%CN¥65.00CN¥52.00n/a3
Nov ’25CN¥52.34
CN¥59.29
+13.3%
7.9%CN¥65.00CN¥52.00n/a4
Oct ’25CN¥48.90
CN¥57.33
+17.2%
5.8%CN¥60.59CN¥52.00n/a4
Sep ’25CN¥39.85
CN¥62.83
+57.7%
10.5%CN¥74.00CN¥57.00n/a4
Aug ’25CN¥43.68
CN¥71.08
+62.7%
10.4%CN¥80.07CN¥59.74n/a4
Jul ’25CN¥42.61
CN¥71.08
+66.8%
10.4%CN¥80.07CN¥59.74n/a4
Jun ’25CN¥52.50
CN¥71.08
+35.4%
10.4%CN¥80.07CN¥59.74n/a4
May ’25CN¥53.41
CN¥71.08
+33.1%
10.4%CN¥80.07CN¥59.74n/a4
Apr ’25CN¥58.29
CN¥76.60
+31.4%
13.1%CN¥92.00CN¥65.44n/a4
Mar ’25CN¥59.66
CN¥75.35
+26.3%
10.8%CN¥87.00CN¥65.44n/a4
Feb ’25CN¥51.17
CN¥75.35
+47.2%
10.8%CN¥87.00CN¥65.44n/a4
Jan ’25CN¥62.03
CN¥77.40
+24.8%
10.8%CN¥87.00CN¥65.44n/a5
Dec ’24CN¥65.93
CN¥77.40
+17.4%
10.8%CN¥87.00CN¥65.44n/a5
Nov ’24CN¥66.32
CN¥75.02
+13.1%
16.3%CN¥87.00CN¥53.51CN¥52.345
Oct ’24CN¥60.14
CN¥72.25
+20.1%
17.0%CN¥87.00CN¥53.51CN¥48.904
Sep ’24CN¥56.70
CN¥72.25
+27.4%
17.0%CN¥87.00CN¥53.51CN¥39.854
Aug ’24CN¥58.18
CN¥82.05
+41.0%
10.0%CN¥88.62CN¥70.52CN¥43.683
Jul ’24CN¥67.90
CN¥82.05
+20.8%
10.0%CN¥88.62CN¥70.52CN¥42.613
Jun ’24CN¥67.81
CN¥82.05
+21.0%
10.0%CN¥88.62CN¥70.52CN¥52.503
May ’24CN¥64.26
CN¥79.57
+23.8%
11.4%CN¥88.62CN¥70.52CN¥53.412
Apr ’24CN¥64.94
CN¥68.97
+6.2%
31.1%CN¥90.44CN¥47.50CN¥58.292
Mar ’24n/a
CN¥68.97
0%
31.1%CN¥90.44CN¥47.50CN¥59.662
Feb ’24n/a
CN¥68.97
0%
31.1%CN¥90.44CN¥47.50CN¥51.172
Jan ’24n/a
CN¥64.91
0%
28.4%CN¥90.44CN¥47.50CN¥62.033
Dec ’23n/a
CN¥64.91
0%
28.4%CN¥90.44CN¥47.50CN¥65.933
Nov ’23n/a
CN¥64.91
0%
28.4%CN¥90.44CN¥47.50CN¥66.323

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.53

7D

-5.8%

1Y

-34.9%

Innovita Biological Technology

CN¥6.0b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥44.03

7D

2.4%

1Y

46.3%

iRay Technology

CN¥16.1b

Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.

688301

CN¥108.85

7D

-3.0%

1Y

-32.1%